コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 2 diaminopyimidines, 1 aminocoumarin, and 1 lincosamide).
2 rythro-alpha-D-gluco-octose to GDP-D-alpha-D-lincosamide.
3 resistance to tetracycline, macrolides, and lincosamides.
4 e therapy are tetracyclines, macrolides, and lincosamides.
5 oles, 89-114% for 3 phenicols, 86-111% for 3 lincosamides, 97-102% for 2 pleuromutilins, 72-88% for 4
6 biotics, including beta-lactams, macrolides, lincosamides, aminoglycosides, chloramphenicol, and fosf
7 nd tlrD) conferring resistance to macrolide, lincosamide and streptogramin B type (MLS) antibiotics w
8 se VmlR confers resistance to pleuromutilin, lincosamide and type A streptogramin translation inhibit
9 namides and trimethoprim (J01E), macrolides, lincosamides and streptogramins (J01F), aminoglycoside a
12 rases (Erms) confer resistance to macrolide, lincosamide, and streptogramin antibiotics in Gram-posit
14 rases (Erms) confer resistance to macrolide, lincosamide, and streptogramin B antibiotics by methylat
16 ycin A against the inducibly MLS (macrolide, lincosamide, and streptogramin B)-resistant organisms.
17 (macrolides, aminoglycosides, tetracyclines, lincosamides, and chloramphenicol), DNA synthesis inhibi
19 istance genes for tetracyclines, macrolides, lincosamides, and streptogramins, and aminoglycosides.
22 le mechanisms of resistance to macrolide and lincosamide antibiotics are present in S. pyogenes strai
23 and infants, and that the development of new lincosamide antibiotics for malaria should be reconsider
25 unusual mechanism of resistance to macrolide-lincosamide antibiotics mediated by mycobacterial HflX,
26 mutant was hypersusceptible to macrolide and lincosamide antibiotics, even in the presence of the erm
27 Antitumor pyrrolobenzodiazepines (PBDs), lincosamide antibiotics, quorum-sensing molecule hormaom
29 etracyclines, macrolides, streptogramins and lincosamides are now accessible through flexible and gen
32 rythromycin, the ketolide telithromycin, the lincosamide clindamycin, and a phenicol, chloramphenicol
35 including erythromycin and azithromycin) and lincosamide (including clindamycin) antibiotics are reco
36 es (ant(6)-Ia, aph(3')-IIIa, sat4, and spw), lincosamides (lnu(B), lsa(A), and lsa(E)), macrolides (e
37 in dental practice or research: beta-lactam, lincosamide, macrolide, nitroimidazole, and tetracycline
40 ords access to a host of rationally designed lincosamides otherwise inaccessible by semisynthesis and
41 ncy, peptide deformylase inhibitors, and new lincosamide, oxazolidinone, lipopeptide and cephalospori
42 large ribosomal subunit, namely macrolides, lincosamides, phenicols, oxazolidinones, pleuromutilins
43 es, nitrofurans, nitroimidazoles, phenicols, lincosamides, pleuromutilins, macrocyclic lactones, quin
44 including sulfonamides, diaminopyrimidines, lincosamides, pleuromutilins, macrolides, cephalosporins
46 our results suggest a mechanism of macrolide-lincosamide resistance in which the mycobacterial HflX d
49 being the most abundant, alongside macrolide-lincosamide-streptogramin and aminoglycoside resistance
50 reus conferred hypersensitivity to macrolide-lincosamide-streptogramin B (MLS(B)) antibiotics on stra
52 or ribosomal target modification (macrolide-lincosamide-streptogramin B [MLSB] resistance; usually e
53 mycin and other antibiotics of the macrolide-lincosamide-streptogramin B group (MLS) is methylation o
55 with the constitutive or inducible macrolide-lincosamide-streptogramin B resistance phenotype (cMLS(B
56 LI and ERY resistant (constitutive macrolide-lincosamide-streptogramin B resistance) demonstrated eit
57 Erm46 plasmid carrying the erm(46) macrolide-lincosamide-streptogramin resistance determinant, and of
58 azole, and rifampin, but inducible macrolide-lincosamide-streptogramin resistance in a subset of CA-M
59 and M. ulcerans, M. tuberculosis (macrolide-lincosamide-streptogramin resistance protein, MLSRP), an
60 sferases confers resistance to the macrolide-lincosamide-streptogramin type B (MLS) antibiotics throu
62 /US resistomes were distinct, with macrolide-lincosamide-streptogramin, phenicol, quinolone, and tetr
63 y a gene conferring resistance to macrolides-lincosamides-streptogramin B, showing that differential
64 est positive effect on transcripts targeting lincosamide/streptogramin, beta-lactam and phenicol/quin
65 ce genes identified coded against macrolides/lincosamides/streptogramins, aminoglycosides, rifampin a
66 nce mechanisms for tetracyclines, macrolides-lincosamides, sulfonamides, aminoglycosides, and beta-la
67 the effect of fluoroquinolone and macrolide/lincosamide usage on resistance of methicillin-resistant
68 s conferring resistance to macrolides and/or lincosamides were found in 56% of isolates; 85.2% of iso